Location: Switzerland
Total raised: $24.62M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.07.2025 | Seed | $24.62M | Boehringer... |
Mentions in press and media 3
| Date | Title | Description |
| 07.07.2025 | EvlaBio secures €21 million in seed funding | Founded with a mission to address high unmet medical need in the cardiorenal field, Swiss German biotech company EvlaBio is developing a targeted treatment for patients suffering from Chronic Kidney Disease (CKD) with limited therapeutic o... |
| 05.06.2023 | A significant number of Swiss biotechs exhibit in Boston | |
| - | EvlaBio | “Home” |